The Washington State AIDS Drug Assistance Program (Early Intervention Program) pays for a variety of services to help meet the health care needs of low-to-moderate income people with HIV who live in Washington.
Frequently Ask Questions FAQs |
Basic requirements for all Washington State Department of Health Prescription Drug Program applicants:
There are additional requirements for some applicants who may be eligible for Medicaid.
Please click on the links below to download a PDF with a complete list of medications on Washington State AIDS Drug Assistance Program (EIP) formulary.
Patients can fill their prescriptions through any one of the participating pharmacies in Washington.
To locate the pharmacy closest to your patient, enter their zip code or city in the form to the right, or call Ramsell Public Health Rx at 1-888-311-7632.
Patients have the right to apply, to appeal decisions and to receive confidential, nondiscriminatory, courteous and respectful service.
If you believe a client has been denied their rights, or treated unfairly or discourteously at any point in the enrollment process, or while receiving pharmacy services, you may contact the local coordinator for your county or the Washington State Department of Health at 1-877-376-9316.
Authorization to receive Fuzeon is given in six-month periods and access to Fuzeon is limited based on the availability of openings.
Please be sure to include any necessary lab measurements that show the patient’s viral load measurement, CD4 count and genotype resistance profile. Download PDF ![]()
Please make sure to fill out EITHER section 1 OR 2 of the application.
Download PDF ![]()
Patients must submit a request for pegylated interferon thru the WA Washington State Department of Health Prescription Drug Program by first submitting this form to Ramsell Public Health Rx. Download PDF ![]()
Patients must fail therapy with both lamivudine and tenofovir prior to therapy with Baraclude. There must be documented treatment failure evidenced by a (+) Hep B DNA and a (+) Hep BeAg (Hep B envelope antigen). Download PDF ![]()
Please fill out Form A for the initial approval only and Form B for subsequent refill requests.
Please be sure to include documented dates and dosage of testosterone therapy when applying for the initial approval. Download PDF ![]()
Maraviroc is approved for patients with CCR5 mono-tropic HIV confirmed by tropism assay results. Please fill out the maraviroc prior authorization form.
Trofile™ test showing "CCR5 only" is required for maraviroc new starts. It is not required for those already on maraviroc through clinical trials, expanded access or other insurance.
The Selzentry (maraviroc) prior authorization access form must be faxed back to the program Pharmacy Benefit Manager, Ramsell Public Health Rx at 800-848-4241.
Download PDF ![]()
Our Heart is in Public Health